B7-33 — single-chain relaxin analog research peptide studied in fibrosis and cardiovascular research models.

B7-33 is a single-chain peptide research compound based on the B-chain of human relaxin-2. While native relaxin is a complex two-chain heterodimer, B7-33 simplifies the molecule while retaining functional activity.
B7-33 selectively activates the RXFP1 receptor (relaxin family peptide receptor 1) and biases ERK1/2 signaling. Research investigates its anti-fibrotic and vasoprotective effects.
Used in: fibrosis research, cardiovascular research, RXFP1 signaling studies, comparative relaxin analog research.
| Compound | B7-33 |
| Available Strengths | 2mg, 10mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.